CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-10 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Returned to the company | −1,370 | $111.40 | $153K | 46,935 |
| 2023-03-10 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Returned to the company | −1,650 | $111.40 | $184K | 45,285 |
| 2023-03-10 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Returned to the company | −2,397 | $111.40 | $267K | 42,888 |
| 2023-03-10 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Returned to the company | −787 | $111.40 | $88K | 42,101 |
| 2023-03-10 | Brown Michael Jon EVP Chief Legal Officer | Returned to the company | −4,812 | $111.40 | $536K | 65,482 |
| 2023-03-10 | Balo Andrew K EVP Regulatory Strategy Clinic | Returned to the company | −3,275 | $111.40 | $365K | 59,303 |
| 2023-03-10 | Balo Andrew K EVP Regulatory Strategy Clinic | Returned to the company | −2,405 | $111.40 | $268K | 56,898 |
| 2023-03-10 | Balo Andrew K EVP Regulatory Strategy Clinic | Returned to the company | −5,990 | $111.40 | $667K | 50,908 |
| 2023-03-10 | Abbey Donald EVP Global Business Services I | Returned to the company | −3,604 | $111.40 | $401K | 216,088 |
| 2023-03-10 | Abbey Donald EVP Global Business Services I | Returned to the company | −4,675 | $111.40 | $521K | 211,413 |
| 2023-03-10 | Abbey Donald EVP Global Business Services I | Returned to the company | −3,390 | $111.40 | $378K | 208,023 |
| 2023-03-08 | Abbey Donald EVP Global Business Services I | Grant or award | +18,776 | $0.00 | $19 | 219,692 |
| 2023-03-08 | Brown Michael Jon EVP Chief Legal Officer | Grant or award | +21,769 | $0.00 | $22 | 70,294 |
| 2023-03-08 | Regan Barry J. EVP Operations | Grant or award | +18,776 | $0.00 | $19 | 78,162 |
| 2023-03-08 | SAYER KEVIN R President CEO and Chairman of | Grant or award | +54,422 | $0.00 | $54 | 385,759 |
| 2023-03-08 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Grant or award | +21,769 | $0.00 | $22 | 48,305 |
| 2023-03-08 | Flynn Paul R EVP Global Revenue | Grant or award | +18,776 | $0.00 | $19 | 74,520 |
| 2023-03-08 | Lawver Teri L EVP Chief Commercial Officer | Grant or award | +45,352 | $0.00 | $45 | 45,352 |
| 2023-03-08 | Leach Jacob Steven EVP Chief Technology Officer | Grant or award | +25,397 | $0.00 | $25 | 306,486 |
| 2023-03-08 | Naganathan Girish EVP Chief Technology Officer | Grant or award | +18,776 | $0.00 | $19 | 50,225 |
Page 19 of 40 · 785 trades